Bioventus announced the launch of Supartz FX (hyaluronic acid) for the management of knee osteoarthritis pain. Bioventus announced the launch of Supartz FX (hyaluronic acid) for the management of knee ...
DURHAM, N.C.--(BUSINESS WIRE)--Beginning January 1, 2020 Bioventus, a global leader in orthobiologic solutions, has secured preferred access for Blue Cross Blue Shield of Michigan Medicare Advantage ...
Bioventus, a global leader in orthobiologic solutions, has entered into an agreement with Seikagaku Corporation to continue distributing Supartz FX in the US after the current distribution agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback